CTLA4 and neoplasm: Treating the animals with CPI (anti-PD-1 and anti-CTLA-4 antibodies) alone showed just little effect on the growth of B16F10 tumors; meanwhile, the collagen-binding domain fused to IL-12 (CBD-IL-12) alone initially induced tumor regression [37].